Abstract Number: 0084 DB-2304, an Immunomodulatory Antibody‒drug Conjugate (ADC) Targeting BDCA2, Displays Strong In Vivo Efficacy in Pharmacodynamic and Psoriasis Models
用户RcsoTKlzyIwM
1个月前
49
10
已关闭

